Insights
More with analytics
Mental Health: How Can Healthcare Companies Join the Wider Debate?
The COVID-19 pandemic has exacerbated preexisting mental health challenges, giving a stronger impetus to the debate around depression and anxiety in both healthcare and mass media. Our media analysis found that the conversation in health industry outlets was mainly...
Machine Learning Meets Media Analysis: From Hype to Reality
First appeared on the AMEC website as part of AMEC's Tech Hub initiative. There is hardly any industry that has not jumped on the AI and Big Data Analytics bandwagon yet, but one notably lags- Public Relations (PR) and Communications. A possible reason for this is...
Cannabis Drinks: How Can PR Normalise the Industry?
The market for cannabis drinks is expanding rapidly, with more and more states legalising marijuana, but mainstream consumer packaged goods marketers are often cautious about entering this industry due to an enduring stigma. Our media analysis found that Canopy Growth...
Going NOLO: How Are Alcohol Brands Tapping Into the Sober-Curious Trend?
Legacy alcohol giants and emerging start-ups are eager to capitalise on the no/low alcohol trend, which has accelerated along with the pandemic-induced rise in health consciousness. Our media analysis found that Heineken and Diageo were the corporate brands with the...
How Is Big Alcohol Trying to Stay Relevant? A Competitive Benchmarking Media Analysis
The global alcohol beverage industry doesn't enjoy a great reputation, with its media presence being continuously tainted by reports about alcohol's negative health effects. In fact, alcohol companies sometimes face very similar reputational challenges like...
The Ready-to-Drink Trend: Can Canned Cocktails and Hard Seltzers Save the Alcohol Industry?
As alcohol consumption is going out of fashion for health-conscious young consumers, RTDs like canned cocktails and hard seltzers are becoming the fastest-growing category in the beverage business, with brands positioning them as better-for-you products. Our analysis...
The Quest for Covid Treatments: What Comms Challenges Is Pharma Facing?
While pharma companies experienced reputational boosts thanks to the rapid vaccine development, they are now facing increasing pressure to introduce new Covid treatments, as more and more experts assert that vaccination alone won't be enough to handle the pandemic....
Big Tobacco: Can a Demonised Industry Fix Its Reputation?
The media continues to be ruthless towards Big Tobacco, as governments present new regulations and NGOs voice even graver concerns about the dangers of smoking. However, the recent media discussion has focused on how several tobacco companies aim to reposition...
mRNA’s Potential Beyond Covid: How Should PR Pros Communicate Medical Innovation?
The pandemic put mRNA in the media spotlight, with many stories reporting that the novel technology could be used beyond Covid. Our analysis found that mRNA's success seen with Pfizer and Moderna has started to change the conversation around diseases such as cancer,...
